1First Department of Propaedeutic Internal Medicine, Joint Rheumatology Program, National & Kapodistrian University
of Athens Medical School, Athens, Greece
2Clinical Research Unit, Dudley Group NHS Foundation Trust, Dudley, UK,
3Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK
Volume 30, Issue 2 - Supplement
Sign in to download the Issue in PDF format.
146823035
Mediterr J Rheumatol 2019;30(Supp 1):63-8
Article Links
The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
Abstract
This paper has no abstract.